ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,863,000 | -87.8% | 32,000 | -86.5% | 0.17% | -84.8% |
| Q4 2017 | $15,250,000 | +59.3% | 236,700 | +29.7% | 1.11% | +17.5% |
| Q3 2017 | $9,576,000 | +57.4% | 182,500 | +40.4% | 0.94% | +19.1% |
| Q2 2017 | $6,082,000 | -30.2% | 130,000 | -26.1% | 0.79% | -43.4% |
| Q1 2017 | $8,714,000 | +250.8% | 176,000 | +329.3% | 1.40% | +72.1% |
| Q4 2016 | $2,484,000 | – | 41,000 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |